SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011464
Filing Date
2024-08-08
Accepted
2024-08-08 07:16:04
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20240630x10q.htm   iXBRL 10-Q 1276678
2 EX-31.1 cgtx-20240630xex31d1.htm EX-31.1 16708
3 EX-31.2 cgtx-20240630xex31d2.htm EX-31.2 16997
4 EX-32.1 cgtx-20240630xex32d1.htm EX-32.1 10062
5 EX-32.2 cgtx-20240630xex32d2.htm EX-32.2 10235
  Complete submission text file 0001558370-24-011464.txt   5351186

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20240630.xsd EX-101.SCH 34457
7 EX-101.CAL cgtx-20240630_cal.xml EX-101.CAL 39519
8 EX-101.DEF cgtx-20240630_def.xml EX-101.DEF 139542
9 EX-101.LAB cgtx-20240630_lab.xml EX-101.LAB 359223
10 EX-101.PRE cgtx-20240630_pre.xml EX-101.PRE 264694
62 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20240630x10q_htm.xml XML 756530
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 241186031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)